-transparent.png){kind=logo}
In an interdisciplinary prospective study 50 patients surgically treated for breast cancer were treated with six monthly courses of aggressive adjuvant chemotherapy (adriamycin and cyclophosphamide) and were randomized to receive either immunotherapy with levamisole or no additional therapy. Probability of disease-free survival for the whole group is 54.9% at 42 months. There was no noticeable difference in disease-free survival for either pre- and postmenopausal women or for patients treated with or without levamisole. The addition of levamisole had no effect on the depression of in vitro immunologic functions during chemotherapy.
Related Publications
M Betzler, and
W Schreml, and
M Lang, and
H P Lohrmann, and
H D Flad, and
P Schlag, and
C Herfarth, and
H Heimpel
June 2007,
Breast cancer research and treatment,
M Betzler, and
W Schreml, and
M Lang, and
H P Lohrmann, and
H D Flad, and
P Schlag, and
C Herfarth, and
H Heimpel
May 1982,
Cancer,
M Betzler, and
W Schreml, and
M Lang, and
H P Lohrmann, and
H D Flad, and
P Schlag, and
C Herfarth, and
H Heimpel
June 1985,
Indian journal of cancer,
M Betzler, and
W Schreml, and
M Lang, and
H P Lohrmann, and
H D Flad, and
P Schlag, and
C Herfarth, and
H Heimpel
May 1999,
Breast cancer research and treatment,
M Betzler, and
W Schreml, and
M Lang, and
H P Lohrmann, and
H D Flad, and
P Schlag, and
C Herfarth, and
H Heimpel
October 1976,
Archives of surgery (Chicago, Ill. : 1960),
M Betzler, and
W Schreml, and
M Lang, and
H P Lohrmann, and
H D Flad, and
P Schlag, and
C Herfarth, and
H Heimpel
July 2004,
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
M Betzler, and
W Schreml, and
M Lang, and
H P Lohrmann, and
H D Flad, and
P Schlag, and
C Herfarth, and
H Heimpel
January 2008,
Current oncology reports,
M Betzler, and
W Schreml, and
M Lang, and
H P Lohrmann, and
H D Flad, and
P Schlag, and
C Herfarth, and
H Heimpel
January 1996,
Breast cancer research and treatment,
M Betzler, and
W Schreml, and
M Lang, and
H P Lohrmann, and
H D Flad, and
P Schlag, and
C Herfarth, and
H Heimpel
January 2005,
Annals of oncology : official journal of the European Society for Medical Oncology,
M Betzler, and
W Schreml, and
M Lang, and
H P Lohrmann, and
H D Flad, and
P Schlag, and
C Herfarth, and
H Heimpel
August 2001,
Annals of oncology : official journal of the European Society for Medical Oncology,
